XOMA Corp (NASDAQ:XOMA)
| 39.10 Delayed Data As of Jan 22 |  +0.65 / +1.68%Today’s Change | 14.14 Today|||52-Week Range 46.32 | -11.39% Year-to-Date |
Latest XOMA News | Press Releases
No recent news for XOMA Corp.
Today’s Trading
| Previous close | 38.66 |
| Today’s open | 38.23 |
| Day’s range | 35.46 - 39.49 |
| Volume | 34,672 |
| Average volume (3 months) | 39,694 |
| Market cap | $421.5M |
Data as of 3:59pm ET, 01/22/2021
Growth & Valuation
| Earnings growth (last year) | +85.81% |
| Earnings growth (this year) | +279.71% |
| Earnings growth (next 5 years) | +36.00% |
| Revenue growth (last year) | +246.67% |
| P/E ratio | NM |
| Price/Sales | 13.02 |
| Price/Book | 8.48 |
Competitors
| ---- | ||
| CUECue Biopharma Inc | +0.35 | +2.55% |
| APLTApplied Therapeutics... | -0.49 | -2.42% |
| SAVACassava Sciences Inc | +0.79 | +6.54% |
Data as of 4:19pm ET, 01/22/2021
Financials
| Next reporting date | March 17, 2021 |
| EPS forecast (this quarter) | $1.29 |
| Annual revenue (last year) | $18.4M |
| Annual profit (last year) | -$2.0M |
| Net profit margin | -10.79% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
